|
SCFD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.739600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.638600E-01 |
| Normal-vs-Stage2 |
1.473850E-01 |
| Normal-vs-Stage3 |
9.394300E-04 |
| Normal-vs-Stage4 |
1.705560E-02 |
| Stage1-vs-Stage2 |
6.054300E-02 |
| Stage1-vs-Stage3 |
1.423890E-04 |
| Stage1-vs-Stage4 |
6.683000E-03 |
| Stage2-vs-Stage3 |
2.975400E-01 |
| Stage2-vs-Stage4 |
4.803200E-01 |
| Stage3-vs-Stage4 |
8.049400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.071600E-02 |
| Normal-vs-AfricanAmerican |
4.334400E-01 |
| Normal-vs-Asian |
2.020000E-01 |
| Caucasian-vs-AfricanAmerican |
8.762600E-01 |
| Caucasian-vs-Asian |
3.777200E-01 |
| AfricanAmerican-vs-Asian |
3.995200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.831800E-02 |
| Normal-vs-Female |
4.051200E-01 |
| Male-vs-Female |
2.411600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.074200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.337200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.409800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.718550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.669000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.910000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.290400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.856200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.312200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.004400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.756000E-02 |
| Normal-vs-Grade 2 |
3.287200E-01 |
| Normal-vs-Grade 3 |
5.214400E-02 |
| Normal-vs-Grade 4 |
3.462100E-02 |
| Grade 1-vs-Grade 2 |
1.250170E-01 |
| Grade 1-vs-Grade 3 |
1.088310E-02 |
| Grade 1-vs-Grade 4 |
4.981500E-03 |
| Grade 2-vs-Grade 3 |
2.695800E-01 |
| Grade 2-vs-Grade 4 |
1.114570E-01 |
| Grade 3-vs-Grade 4 |
3.353000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.579800E-01 |
| Normal-vs-ccB subtype |
3.726600E-01 |
| ccA subtype-vs-ccB subtype |
7.716600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.192000E-01 |
| Normal-vs-N1 |
5.683800E-02 |
| N0-vs-N1 |
1.267230E-01 |
|
|
